Tamara ThomasDiabetes | November 13, 2023
“New ED diagnoses are associated with previously undiagnosed prediabetes and T2D."
Read More
Tamara ThomasDiabetes | October 13, 2023
Clinical pharmacist Thomas So, PharmD, discusses the prevelence of these conditions and therapies available to treat them.
Tamara ThomasEye Disease | September 20, 2023
Eye specialists are unsure when anti-VEGF treatment should start to achieve the best long-term outcome
Tamara ThomasEye Disease | September 12, 2023
An estimated 9.6 million people in the U.S. had diabetic-related eye disease – roughly 26% of diabetics.
Tamara ThomasDiabetes | August 29, 2023
Approximately 70% of new diagnoses of type 2 diabetes worldwide have been linked to poor diet.
Tamara ThomasDiabetes | August 25, 2023
Artificial sweeteners may be just as harmful as sugar as it accumulates in adipose tissue and may result in obesity.
Rebecca AraujoDiabetes | August 4, 2023
Initiatives to increase health literacy in individuals with type 2 diabetes may be effective at improving glycemic control.
Tamara ThomasDiabetes | April 12, 2023
"...diabetes is now one of the most common health disparities among indigenous peoples."
Tamara ThomasDiabetes | March 24, 2023
Endocrine-disrupting chemicals (EDCs) in plastics could increase the likelihood of women developing diabetes.
Lou PorteroManaged Care | February 15, 2023
Most Medicare diabetics don't receive a prescription for continuous blood glucose monitoring or use the technology correctly.
Lou PorteroDiabetes | February 1, 2023
According to the researchers, type 2 diabetes diagnoses could increase by nearly 70% by 2060.
Rob DillardDiabetes | July 18, 2022
Social, economic, and environmental barriers can play a role in one's risk of diabetes.
Urban Health Today EditorsMultiple Myeloma | December 16, 2021
A study of individuals with multiple myeloma (MM) revealed significant racial disparities in the prevalence of obesity ...
JC LandryDiabetes | November 4, 2020
Dr. Subramanian discusses the impact of race on short-term treatment response to bevacizumab (Avastin).
Latest News

November 30, 2023